Feb 20, 2017 at 10:19 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com is of the view that one can sell Havells India and Dr Reddy's Labs and advises buying Petronet LNG and Siemens.
Feb 20, 2017 at 09:48 | Source: Moneycontrol.com
Goldman Sachs says Kotak Mahindra Bank may outperform on improving growth prospects & top quartile EPS growth. Lending book is likely to grow at 25 percent hereon, it feels.
Feb 18, 2017 at 10:42 | Source: Moneycontrol.com
Indian ADRs ended mostly lower on Friday. HDFC Bank fell 0.28 percent and Dr Reddy's Laboratories fell 0.28 percent.
Feb 17, 2017 at 13:46 | Source: PTI
Drug major Dr Reddy's Laboratories had received an unfavourable ruling in a US court regarding a patent infringement case over anti-nausea injection Aloxi.
Feb 17, 2017 at 08:11 | Source: Moneycontrol.com
Indian ADRs ended mostly higher on Thursday. Tata Motors added 2.04 percent and Wipro was up 0.42 percent.
Feb 16, 2017 at 14:56 | Source: CNBC-TV18
CNBC-TV18's Ekta Batra lists six stocks that you should focus on Infosys, Tata Consultancy Services (TCS), Dr Reddys Laboratories, Sun Pharmaceutical Industries, State Bank of India (SBI) and GAIL India.
Feb 16, 2017 at 13:30 | Source: CNBC-TV18
Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today Dr Reddys, TCS, Fortis Health, SBI and IL&FS Engineering.
Feb 16, 2017 at 11:52 | Source: CNBC-TV18
Mitessh Thakkar of miteshthacker.com is of the view that one can buy Dr Reddys Laboratories 2850 Put while he feels that the trend in Tata Motors DVR is on the downside.
Feb 16, 2017 at 11:14 | Source: PTI
In a BSE filing, Reddy's Laboratories said: "The United States District Court for the District of New Jersey issued its opinion regarding Helsinn Healthcare's patent infringement claims against Dr Reddy's proposed palonosetron product".
Feb 16, 2017 at 10:31 | Source: Moneycontrol.com
Dr Reddy's on Thursday said it received an unfavorable ruling in a US court regarding a patent infringement case over its anti-nausea injection Aloxi. It said the US Court for the District of New Jersey had issued its opinion regarding Helsinn Healthcare's patent infringement claims against Dr Reddy's proposed palonosetron product.